Influence of Carcinoma and Sarcoma on Neutrophil Gelatinase-Associated Lipocalin and Symmetric Dimethylarginine Concentrations in Dogs
Open Access
- 1 March 2025
- journal article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 39 (2) , e70015
Abstract
Background: It is unknown if tumors or concomitant renal disease influence neutrophil gelatinase–associated lipocalin (NGAL) and symmetric dimethylarginine (SDMA) concentrations in tumor-bearing dogs. Objectives: Determine the effect of tumor presence, tumor type, and metastasis on concentrations of serum NGAL (sNGAL), SDMA, urinary NGAL (uNGAL), and uNGAL-to-creatinine ratio (uNGAL/Cr) in dogs with carcinoma or sarcoma without clinically relevant renal disease. Animals: Twenty-one dogs with carcinoma, 18 with sarcoma, and 20 healthy age-controlled dogs. Methods: Concentrations of sNGAL, SDMA, and uNGAL, and uNGAL/Cr ratio were measured from banked samples collected during a previous prospective study. Patient clinicopathological and histopathology records were reviewed, and those with renal azotemia or moderate to severe histopathological renal abnormalities were classified as having clinically relevant renal disease. Biomarker concentrations were compared between tumor-bearing dogs without clinically relevant renal disease and healthy age-controlled dogs. Additionally, comparisons were made between dogs with carcinoma and sarcoma, as well as between dogs with and without metastasis. Correlations between uNGAL and sNGAL concentrations, along with acute phase protein (APP) concentrations, were also analyzed. Results: Tumor-bearing dogs without clinically relevant renal disease had increased uNGAL/Cr (p < 0.001), but not sNGAL, compared with healthy controls. Although median SDMA concentrations did not significantly differ between groups, increased concentrations were found in 32% of dogs with carcinoma and 20% of dogs with sarcoma. No differences were found between dogs with carcinoma and those with sarcoma, or between dogs with metastasis and those without. Urinary and serum NGAL concentrations were moderately correlated, while weak to no correlations were observed with APPs. Conclusion: Carcinomas and sarcomas, but not metastasis, influence uNGAL/Cr and SDMA concentrations in dogs.Keywords
Funding Information
- Department of Companion Animal Clinical Studies Research Fund, University of Pretoria
- Faculty of Veterinary Science, Ghent University
- Faculty of Veterinary Science, Chulalongkorn University
This publication has 65 references indexed in Scilit:
- NGAL Expression Is Elevated in Both Colorectal Adenoma–Carcinoma Sequence and Cancer Progression and Enhances Tumorigenesis in Xenograft Mouse ModelsClinical Cancer Research, 2011
- Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rateKidney International, 2010
- Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: Correlation with histotype and histological gradeOncology Reports, 2010
- Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer diseaseBMC Cancer, 2009
- Mechanisms of Cancer CachexiaPhysiological Reviews, 2009
- Lipocalin 2 Expressions Correlate Significantly With Tumor Differentiation in Epithelial Ovarian CancerJournal of Histochemistry & Cytochemistry, 2009
- Urinary Biomarkers Predict Brain Tumor Presence and Response to TherapyClinical Cancer Research, 2008
- Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancerEuropean Journal of Cancer, 2007
- The in vitro effects of piroxicam and meloxicam on canine cell linesJournal of Small Animal Practice, 2006
- The Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Plays a Role in Breast Tumor Growth and Is Present in the Urine of Breast Cancer PatientsClinical Cancer Research, 2005